THOMAS C FREYMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS C FREYMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS C FREYMAN. THOMAS C FREYMAN is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Executive VP, Finance & CFO in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT) and Director in TENNECO INC ($TEN).
Latest Insider Trading Transactions of THOMAS C FREYMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 16 2015 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Jul 16 2014 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Sell | J | 0.00 | 1,589 | 0 | 0 | 1.6 K to 0 (-100.00 %) |
Jul 16 2014 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Buy | J | 0.00 | 1,589 | 0 | 8,572 | 7 K to 8.6 K (+22.76 %) |
Jul 22 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 25.25 | 56,000 | 1,413,782 | 56,000 | |
Jul 22 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 21.22 | 23,000 | 488,046 | 0 | |
Jul 22 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 42.73 | 60,702 | 2,593,796 | 329,624 | 390.3 K to 329.6 K (-15.55 %) |
Jul 22 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 25.25 | 56,000 | 1,413,782 | 390,326 | 334.3 K to 390.3 K (+16.75 %) |
Jul 22 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 21.22 | 23,000 | 488,046 | 334,326 | 311.3 K to 334.3 K (+7.39 %) |
Jan 17 2014 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 1,589 | 0 | 1,589 | 0 to 1.6 K |
Mar 04 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 39.10 | 2,984 | 116,686 | 311,326 | 314.3 K to 311.3 K (-0.95 %) |
Mar 04 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 39.79 | 27,660 | 1,100,591 | 314,310 | 342 K to 314.3 K (-8.09 %) |
Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 39.12 | 200,477 | 7,842,660 | 200,477 | |
Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 32,746 | 0 | 341,970 | 309.2 K to 342 K (+10.59 %) |
Oct 23 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 34.93 | 42,487 | 1,484,071 | 0 | |
Oct 23 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 37.29 | 41,059 | 1,531,090 | 309,224 | 350.3 K to 309.2 K (-11.72 %) |
Oct 23 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 34.93 | 42,487 | 1,484,071 | 350,283 | 307.8 K to 350.3 K (+13.80 %) |
Jul 16 2013 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Sell | J | 0.00 | 2,483 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
Jul 16 2013 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Buy | J | 0.00 | 2,483 | 0 | 6,983 | 4.5 K to 7 K (+55.18 %) |
May 03 2013 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Buy | P | 38.26 | 1,500 | 57,390 | 4,500 | 3 K to 4.5 K (+50.00 %) |
Apr 03 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 22.27 | 63,800 | 1,420,635 | 0 | |
Apr 03 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 35.32 | 50,917 | 1,798,388 | 307,796 | 358.7 K to 307.8 K (-14.19 %) |
Apr 03 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 22.27 | 63,800 | 1,420,635 | 358,713 | 294.9 K to 358.7 K (+21.63 %) |
Jan 18 2013 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,483 | 0 | 2,483 | 0 to 2.5 K |
Mar 14 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 34.93 | 42,487 | 1,484,071 | 42,487 | |
Mar 14 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 26.09 | 16,384 | 427,488 | 0 | |
Mar 14 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 25.25 | 33,180 | 837,825 | 0 | |
Mar 14 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 34.93 | 42,487 | 1,484,071 | 294,913 | 337.4 K to 294.9 K (-12.59 %) |
Mar 14 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 26.09 | 16,384 | 427,488 | 337,400 | 321 K to 337.4 K (+5.10 %) |
Mar 14 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 25.25 | 33,180 | 837,825 | 321,016 | 287.8 K to 321 K (+11.53 %) |
Mar 01 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 34.26 | 28,188 | 965,721 | 287,836 | 316 K to 287.8 K (-8.92 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 34.94 | 299,300 | 10,457,542 | 299,300 | |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 35.08 | 15,024 | 527,042 | 316,024 | 331 K to 316 K (-4.54 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 57,500 | 0 | 331,048 | 273.5 K to 331 K (+21.02 %) |
Dec 14 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 76,000 | 0 | 76,000 | 0 to 76 K |
Dec 14 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 76,000 | 0 | 76,000 | 0 to 76 K |
Dec 14 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 76,000 | 0 | 4,000 | 80 K to 4 K (-95.00 %) |
Dec 14 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 65,000 | 0 | 80,000 | 15 K to 80 K (+433.33 %) |
Dec 14 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 76,000 | 0 | 273,548 | 349.5 K to 273.5 K (-21.74 %) |
Dec 14 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 65,000 | 0 | 349,548 | 414.5 K to 349.5 K (-15.68 %) |
Sep 25 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 44.16 | 30,000 | 1,324,800 | 23,000 | |
Sep 25 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 69.86 | 23,538 | 1,644,365 | 414,548 | 438.1 K to 414.5 K (-5.37 %) |
Sep 25 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 44.16 | 30,000 | 1,324,800 | 438,086 | 408.1 K to 438.1 K (+7.35 %) |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 44.16 | 30,000 | 1,324,800 | 53,000 | |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 65.06 | 24,357 | 1,584,666 | 408,086 | 432.4 K to 408.1 K (-5.63 %) |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 44.16 | 30,000 | 1,324,800 | 432,443 | 402.4 K to 432.4 K (+7.45 %) |
May 04 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 58.90 | 25,602 | 1,507,958 | 0 | |
May 04 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 62.65 | 24,705 | 1,547,768 | 402,443 | 427.1 K to 402.4 K (-5.78 %) |
May 04 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 58.90 | 25,602 | 1,507,958 | 427,148 | 401.5 K to 427.1 K (+6.38 %) |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 54.67 | 25,701 | 1,405,074 | 0 | |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 52.55 | 26,572 | 1,396,359 | 0 | |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 60.22 | 24,314 | 1,464,189 | 401,546 | 425.9 K to 401.5 K (-5.71 %) |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 60.22 | 24,590 | 1,480,810 | 425,860 | 450.5 K to 425.9 K (-5.46 %) |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 54.67 | 25,701 | 1,405,074 | 450,450 | 424.7 K to 450.5 K (+6.05 %) |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 52.55 | 26,572 | 1,396,359 | 424,749 | 398.2 K to 424.7 K (+6.67 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 57.04 | 27,207 | 1,551,887 | 398,177 | 425.4 K to 398.2 K (-6.40 %) |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 56.26 | 107,300 | 6,036,698 | 107,300 | |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 59,400 | 0 | 425,384 | 366 K to 425.4 K (+16.23 %) |
Dec 23 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 53.63 | 95,764 | 5,135,345 | 0 | |
Dec 23 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 54.86 | 94,483 | 5,183,337 | 365,984 | 460.5 K to 366 K (-20.52 %) |
Dec 23 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 53.63 | 95,764 | 5,135,345 | 460,467 | 364.7 K to 460.5 K (+26.26 %) |
Aug 09 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.19 | 10,200 | 501,748 | 364,703 | 374.9 K to 364.7 K (-2.72 %) |
Aug 09 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.19 | 100 | 4,919 | 374,903 | 375 K to 374.9 K (-0.03 %) |
Aug 09 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.19 | 100 | 4,919 | 375,003 | 375.1 K to 375 K (-0.03 %) |
Aug 09 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.19 | 100 | 4,919 | 375,103 | 375.2 K to 375.1 K (-0.03 %) |
Aug 09 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.19 | 9,500 | 467,305 | 375,203 | 384.7 K to 375.2 K (-2.47 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.44 | 300 | 15,732 | 384,703 | 385 K to 384.7 K (-0.08 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.44 | 600 | 31,461 | 385,003 | 385.6 K to 385 K (-0.16 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.43 | 400 | 20,972 | 385,603 | 386 K to 385.6 K (-0.10 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.42 | 314 | 16,460 | 386,003 | 386.3 K to 386 K (-0.08 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.41 | 1,200 | 62,892 | 386,317 | 387.5 K to 386.3 K (-0.31 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.41 | 1,000 | 52,405 | 387,517 | 388.5 K to 387.5 K (-0.26 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.40 | 100 | 5,240 | 388,517 | 388.6 K to 388.5 K (-0.03 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.40 | 1,572 | 82,373 | 388,617 | 390.2 K to 388.6 K (-0.40 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.40 | 300 | 15,720 | 390,189 | 390.5 K to 390.2 K (-0.08 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.40 | 600 | 31,437 | 390,489 | 391.1 K to 390.5 K (-0.15 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.39 | 1,000 | 52,390 | 391,089 | 392.1 K to 391.1 K (-0.26 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.38 | 700 | 36,666 | 392,089 | 392.8 K to 392.1 K (-0.18 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.37 | 1,465 | 76,722 | 392,789 | 394.3 K to 392.8 K (-0.37 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.37 | 1,700 | 89,021 | 394,254 | 396 K to 394.3 K (-0.43 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.36 | 400 | 20,944 | 395,954 | 396.4 K to 396 K (-0.10 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.35 | 500 | 26,175 | 396,354 | 396.9 K to 396.4 K (-0.13 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.34 | 364 | 19,052 | 396,854 | 397.2 K to 396.9 K (-0.09 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.34 | 400 | 20,934 | 397,218 | 397.6 K to 397.2 K (-0.10 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.33 | 4,085 | 213,768 | 397,618 | 401.7 K to 397.6 K (-1.02 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.33 | 2,700 | 141,278 | 401,703 | 404.4 K to 401.7 K (-0.67 %) |
May 11 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.32 | 300 | 15,696 | 404,403 | 404.7 K to 404.4 K (-0.07 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 47.64 | 23,076 | 1,099,341 | 404,703 | 427.8 K to 404.7 K (-5.39 %) |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 46.60 | 86,300 | 4,021,580 | 86,300 | |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 61,300 | 0 | 427,779 | 366.5 K to 427.8 K (+16.73 %) |
Oct 27 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 52.94 | 22,019 | 1,165,684 | 777 | 22.8 K to 777 (-96.59 %) |
Sep 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Sep 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 15,000 | 0 | 366,479 | 381.5 K to 366.5 K (-3.93 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.24 | 5,685 | 279,929 | 381,479 | 387.2 K to 381.5 K (-1.47 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.24 | 300 | 14,771 | 387,164 | 387.5 K to 387.2 K (-0.08 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.23 | 7,701 | 379,120 | 387,464 | 395.2 K to 387.5 K (-1.95 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.23 | 1,000 | 49,225 | 395,165 | 396.2 K to 395.2 K (-0.25 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.22 | 2,384 | 117,340 | 396,165 | 398.5 K to 396.2 K (-0.60 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.21 | 2,332 | 114,758 | 398,549 | 400.9 K to 398.5 K (-0.58 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.20 | 100 | 4,920 | 400,881 | 401 K to 400.9 K (-0.02 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.14 | 100 | 4,914 | 400,981 | 401.1 K to 401 K (-0.02 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.12 | 100 | 4,912 | 401,081 | 401.2 K to 401.1 K (-0.02 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.10 | 100 | 4,910 | 401,181 | 401.3 K to 401.2 K (-0.02 %) |
Jul 28 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 49.01 | 198 | 9,704 | 401,281 | 401.5 K to 401.3 K (-0.05 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 54.12 | 17,781 | 962,308 | 401,479 | 419.3 K to 401.5 K (-4.24 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 54.50 | 87,100 | 4,746,950 | 87,100 | |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 32,000 | 0 | 419,260 | 387.3 K to 419.3 K (+8.26 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 59,400 | 0 | 387,260 | 327.9 K to 387.3 K (+18.12 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 374 | 0 | 1,941 | 1.6 K to 1.9 K (+23.87 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 374 | 0 | 1,941 | 1.6 K to 1.9 K (+23.87 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 374 | 0 | 1,941 | 1.6 K to 1.9 K (+23.87 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.92 | 500 | 26,961 | 327,860 | 328.4 K to 327.9 K (-0.15 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.92 | 700 | 37,744 | 328,360 | 329.1 K to 328.4 K (-0.21 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.92 | 900 | 48,529 | 329,060 | 330 K to 329.1 K (-0.27 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 53.93 | 6,433 | 346,932 | 329,960 | 336.4 K to 330 K (-1.91 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 1,122 | 0 | 336,393 | 337.5 K to 336.4 K (-0.33 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.40 | 200 | 10,680 | 337,515 | 337.7 K to 337.5 K (-0.06 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.39 | 2,000 | 106,780 | 337,715 | 339.7 K to 337.7 K (-0.59 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.38 | 1,900 | 101,422 | 339,715 | 341.6 K to 339.7 K (-0.56 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.37 | 1,600 | 85,392 | 341,615 | 343.2 K to 341.6 K (-0.47 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.36 | 1,500 | 80,040 | 343,215 | 344.7 K to 343.2 K (-0.44 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.35 | 4,300 | 229,405 | 344,715 | 349 K to 344.7 K (-1.23 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.34 | 4,000 | 213,360 | 349,015 | 353 K to 349 K (-1.13 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.33 | 5,000 | 266,650 | 353,015 | 358 K to 353 K (-1.40 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.32 | 3,700 | 197,284 | 358,015 | 361.7 K to 358 K (-1.02 %) |
Feb 03 2010 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.31 | 800 | 42,648 | 361,715 | 362.5 K to 361.7 K (-0.22 %) |
Nov 13 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 53.50 | 20,000 | 1,070,000 | 362,515 | 382.5 K to 362.5 K (-5.23 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 50.58 | 7,760 | 392,501 | 382,515 | 390.3 K to 382.5 K (-1.99 %) |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 54.14 | 108,200 | 5,857,948 | 108,200 | |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 76,200 | 0 | 390,275 | 314.1 K to 390.3 K (+24.26 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 54.41 | 254 | 13,821 | 314,075 | 314.3 K to 314.1 K (-0.08 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 54.41 | 200 | 10,883 | 314,329 | 314.5 K to 314.3 K (-0.06 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 54.41 | 100 | 5,441 | 314,529 | 314.6 K to 314.5 K (-0.03 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 54.41 | 100 | 5,441 | 314,629 | 314.7 K to 314.6 K (-0.03 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 54.41 | 100 | 5,441 | 314,729 | 314.8 K to 314.7 K (-0.03 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 54.41 | 100 | 5,441 | 314,829 | 314.9 K to 314.8 K (-0.03 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Sell | S | 54.41 | 100 | 5,441 | 314,929 | 315 K to 314.9 K (-0.03 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 54.94 | 2,808 | 154,272 | 315,029 | 317.8 K to 315 K (-0.88 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 52.55 | 20,882 | 1,097,349 | 0 | |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 370 | 0 | 1,567 | 1.2 K to 1.6 K (+30.91 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 370 | 0 | 1,567 | 1.2 K to 1.6 K (+30.91 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 370 | 0 | 1,567 | 1.2 K to 1.6 K (+30.91 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 56.98 | 19,778 | 1,126,950 | 317,837 | 337.6 K to 317.8 K (-5.86 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 52.55 | 20,882 | 1,097,349 | 337,615 | 316.7 K to 337.6 K (+6.59 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 1,693 | 0 | 316,733 | 318.4 K to 316.7 K (-0.53 %) |
Jul 23 2008 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 53.19 | 27,848 | 1,481,235 | 0 | |
Jul 23 2008 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 57.58 | 26,563 | 1,529,498 | 318,426 | 345 K to 318.4 K (-7.70 %) |
Jul 23 2008 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 53.19 | 27,848 | 1,481,235 | 344,989 | 317.1 K to 345 K (+8.78 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 54.22 | 3,630 | 196,819 | 317,141 | 320.8 K to 317.1 K (-1.13 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 55.56 | 127,500 | 7,083,900 | 127,500 | |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Gift | G | 0.00 | 352 | 0 | 1,197 | 845 to 1.2 K (+41.66 %) |